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CONCLUSION: At this stage, the CONTILIFE® ques-
tionnaire can be used in trials to assess the impact of all
types of UI on QoL. Its responsiveness over time is still to
be documented.
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There have been a number of claims that the MOS SF-36
mean scores can be used to discriminate between healthy
and non-healthy persons and that it can also discriminate
various levels of health.
OBJECTIVES: The purpose of this study was to evaluate
the ability of the SF-36 to predict whether or not respon-
dents reported physician determined illness and whether
or not respondents perceived themselves to have health
problems.
METHODS: We used structural equation modeling
(SEM) techniques to evaluate the SF-36 and its ability to
discriminate between those who reported health prob-
lems or reported physician determined illness and those
who did not in a sample taken from the 1990 National
Survey of Functional Health Status (NHS).
RESULTS: The correlation between physician deter-
mined illness and Physical Health was 0.404, resulting
in 16.32% shared variance. The correlation between re-
ported health problems and Physical Health was 0.360,
resulting in 12.96% shared variance. These correlations
are markedly lower than those to the eight first-order
scales or between Physical and Mental Health (r  .889).
Mental Health could not predict physician determined
illness or reported health problems independent of Physi-
cal Health.
CONCLUSIONS: The SF-36 is relatively poor at account-
ing for the health status of the respondents. There are sig-
nificant paths but the variance accounted for in absolute
and relative terms is small. Physical Health does a much
better job of accounting for general mental health than it
does for perceived health problems or physician deter-
mined illness. These findings suggest that the SF-36 may
not discriminate well between healthy and non-healthy
groups and that objective measures of health status may
be required in conjunction with the use of the SF-36.
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Few data are available on the quality of life (QoL) of
Crohn disease (CD) patients.
OBJECTIVES: To assess the QoL of CD patients pro-
spectively over 1 year and to determine possible factors
of influence.
METHODS: At M0, M3, M6, M9, and M12, patients
had to fill out a self-administered QoL questionnaire. Inves-
tigators completed a clinical form referring to the period of
3 months prior to the visit. The QoL questionnaire was
made up of the SF-36 and the RFIPC (questionnaire spe-
cific to inflammatory bowel disease). The correlation be-
tween QoL and the evolution of the disease was assessed
by both patients and investigators by means of a visual
analog scale.
RESULTS: For this study 231 CD patients were included
by 19 centers from the GETAID: they were 33 years old
on average, 57% were women, 47% were smokers. Pa-
tients had CD for 8.7 years on average. At M0, the SF-36
scores of CD patients were significantly lower than those
of a standard population. Nevertheless, the CD patients’
scores improved over time. The main worries of CD pa-
tients, as measured by the RFIPC, were “having an os-
tomy bag,” “uncertain nature of the disease,” “energy
level,” and “having surgery.” Correlation of patients’ as-
sessment of the evolution of CD and QoL was signifi-
cantly higher than that of the investigators. Significant
factors of an impairment in QoL were: gender, smoking
habits, active CD, hospitalization, and surgery in the past
3 months. Conversely, in-take of immunosuppressive
drug was a significant factor of QoL improvement. Im-
pact on QoL of medical treatment was not related to ac-
tivity of disease.
CONCLUSION: Patients’ QoL is impaired by CD and
such impairment is probably underestimated by clini-
cians. Smoking habits, hospitalization and use of corti-
coids, which are factors known as having a negative im-
pact on QoL, could be acted on. Conversely, the use of
an immunosuppressive drug could be prompted consider-
ing its positive impact on QoL.
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Assessing health status and health preference through dif-
ferent measures has become increasingly important. Re-
cent research has provided a cross-translation algorithm
from SF-36 to the Health Utility Index.
OBJECTIVE: The present research substantiates the pre-
vious cross-translating procedures by estimating algo-
rithms specific to chronic diseases.
METHOD: Data were obtained from Southern Califor-
nia Kaiser-Permanente patients during 1992–1995. Health
